Bupropion HCL and sleep in patients with depression

Current Psychiatry Reviews

Volumn 3, Issue 2, 2007, Pages 123-128

  Krystal, Andrew D ^a   Thase, Michael E ^b   Tucker, Vivian L ^c   Goodale, Elizabeth P ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Antidepressants; Insomnia; Periodic leg movements; REM sleep; Sedation; Sleep electroencephalogram

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DOPAMINE; ESCITALOPRAM; FLUOXETINE; LEVODOPA; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CLINICAL PRACTICE; CLINICAL TRIAL; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FUNCTIONAL ASSESSMENT; HUMAN; INSOMNIA; LIMB DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RELAPSE; REM SLEEP; REVIEW; RISK ASSESSMENT; SLEEP DISORDER; SLEEP WAKING CYCLE;

EID: 34248642602     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340007780599096     Document Type: Review

References (77)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000.
2. Thase ME. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 1999; 60 Suppl 17:28-31.
3. Benazzi F. Late-life atypical major depressive episode: A 358-case study in outpatients. Am J Geriatr Psychiatry 2000; 8(2): 117-122.
4. Gillin JC, Duncan W, Pettigrew KD, et al. Successful separation of depressed, normal, and insomniac subjects by EEG sleep data. Arch Gen Psychiatry 1979; 36: 85-90.
5. Kupfer DJ, Ulrich RF, Coble PA, et al. Elextroencephalographic sleep of younger depressives. Comparison with normals. Arch Gen Psychiatry 1985; 42: 806-10.
6. Walter DA, Hardy BW, Pole R, et al. Sleep EEG in bulimic, depressed and normal subjects. Biol Psychiatry 1989; 25: 661-4.
7. Berger M, Doerr P, Lund R, Bronisch T, von Zerssen D. Neuroendocrinological and neurophysiological studies in major depressive disorders: Are there biological markers of the endogenous subtype? Biol Psychiatry 1982; 17: 1217-42.
8. Kupfer DJ, Heninger GR. REM activity as a correlate of mood changes throughout the night. Electroencephalographic sleep patterns in a patient with a 48-hour cyclic mood disorder. Arch Gen Psychiatry 1972; 27: 368-73.
9. Hartmann E, Verdone P, Snyder F. Longitudinal studies of sleep and dreaming patterns in psychiatric patients. J Nerv Ment Dis 1966; 142: 117-26.
10. Mendels J, Hawkins DR. The psychophysiology of sleep in depression. Ment Hyg 1967; 51: 501-11.
11. Snyder F. Sleep of the body. Biol Psychiatry 1969; 27: 271-81.
12. Kupfer DJ, Targ E, Stack J. Electroencephalographic sleep in unipolar depressive subtypes: support for a biological and familiar classification. J Nerv Ment Dis 1982; 170: 494-8.
13. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 1992; 49: 651-68.
14. Kupfer DJ, Frank E, Ehlers CL. EEG sleep in young depressives: first and second night effects. Biol Psychiatry 1989; 25: 87-97.
15. Quitkin FM, Rabkin JG, Stewart JW, et al. Sleep of atypical depressives. J Affect Disord 1985; 8: 61-67.
16. Emslie GJ, Rush AJ, Weinberg WA, Rintelmann JW, Roffwarg HP. Children with major depression show reduced rapid eye movement latencies. Arch Gen Psychiatry 1990; 47: 119-124.
17. Akiskal HS, Lemmi H, Yervanian B, King D, Belluomini J. The utility of the REM latency test in psychiatric diagnosis: a study of 81 depressed outpatients. Psychiatry Res 1982; 7: 101-110.
18. Jones D, Kelwala S, Bell J, Dube S, Jackson E, Sitaram N. Chlolinergic REM sleep induction response correlation with endogenous major depressive subtype. Psychiatry Res 1985; 14: 99-110.
19. Foster FG, Kupfer DJ, Coble P, McPartland RJ. Rapid eye movement sleep density. An objective indicator in severe medical-depressive syndromes. Arch Gen Psychiatry 1976; 33: 1119-23.
20. Borbely AA, Wirz-Justice A. Sleep, sleep deprivation and depression. A hypothesis derived from a model of sleep regulation. Hum Neurobiol 1982; 1: 205-210.
21. Feinberg M, Gillin JC, Carroll BJ, Greden IF, Zis AP. EEG studies of sleep in the diagnosis of depression. Biol Psychiatry 1982; 17: 305-316.
22. McCall WV, Reboussin BA, Cohen W. Subjective measurement of insomnia and quality of life in depressed in-patients. J Sleep Res 2000; 9: 43-48.
23. Turvey CL, Conwell Y, Jones MP, et al. Risk factors for late-life suicide: a prospective, community-based study. Am J Geriatr Psychiatry 2002; 4: 398-406.
24. Agargun MY, Kara H, Solmaz M. Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry 1997; 58: 249-51.
25. Fawcett J, Scheftner WA, Fogg L, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1991; 148: 1189-94.
26. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999; 60: 221-225.
27. Nierenberg AA, Petersen TJ, Alpert JE. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. J Clin Psychiatry 2003; 64: Suppl 15: 13-7.
28. Asnis GM, Chakraburtty A, DuBofff EA, et al. Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry 1999; 60: 668-76.
29. Reynolds CF 3rd, Frank E, Houck PR, Mazumdar S, Dew MA, Cornes C, Buysse DJ, Begley A, Kupfer DJ. Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication? Am J Psychiatry 1997; 154: 958-62.
30. Nierenberg AA, Wright EC. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry 1999; 60 Suppl 22: 7-11.
31. Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006; 59: 1052-60.
32. Giles DE, Jarrett RB, Roffward HP, Rush AJ. Reduced rapid eye movement latency. A predictor of recurrences in depression. Neuropsychopharmacology 1987; 1: 33-39.
33. Gillin JC, Wyatt RJ, Fram D, Shyder F. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology (Berl) 1978; 59: 267-272.
34. Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH. Sleep and treatment prediction in endogenous depression. Am J Psychiatry 1981; 138: 429-434.
35. Thase ME. Depression and sleep: pathophysiology and treatment. Dialogues Clin Neurosci 2006; 8: 217-26.
36. Mayers AG, Baldwin DS. Antidepressants and their effect on sleep. Hum Psychopharmacol 2005; 20: 533-59.
37. Stahl SM. Essential Psychopharmacology. 2nd Ed. New York: Cambridge University Press, 2000.
38. Mayers AG, Baldwin DA. Antidepressants and their effect on sleep. Hum Psychopharmacol. 2005; 20: 533-559.
39. Richelson E. Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance. J Clin Psychiatry 2003; 64 Suppl 13: 5-12.
40. Baldessarini R. Drug therapy of depression and anxiety disorders: In: Goodman and Gilmans: The Pharmacologic Basis of Therapeutics, 11th Ed. NewYork: McGraw-Hill; 2006.
41. Hu XH, Scott AB, Hunkeler EM, et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 2004; 65: 959-965.
42. Fava M, Rush AJ, Thase ME, et al. 15 years of clinical experience with bupropion HC1: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry 2005; 7(3): 106-13.
43. Sharpley AL, Williamson DJ, Attenburrow ME, Pearson G, Sargent P, Cowen PJ. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology 1996; 126: 50-54.
44. Poland RE, McCracken JT, Lutchmansingh P, et al. Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects. Biol Psychiatry 1997; 41(9): 929-938.
45. Maes M, Westenberg H, Vandoolaeghe E, et al. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of metachlorophenylpiperazine. J Clin Psychopharmacol 1997; 17(5): 358-364.
46. Ware JC, Pittard JT. Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults. J Clin Psychiatry 1990; 51 Suppl: 18-22.
47. Winokur A, Sateia MJ, Hayes JB, Bayles-Dazet W, MacDonald MM, Gary KA. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study. Biol Psychiatry 2000; 48(1): 75-78.
48. Aslan S, Isik E, Cosar B. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers. Sleep 2002; 25(6): 677-679.
49. Schittecatte M, Dumont F, Machowski R, Cornil C, Lavergne F, Wilmotte J. Effects of mirtazapine on sleep polygraphic variables in major depression. Neuropsychobiology 2002; 46(4): 197-201.
50. Winkelman JW, James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004; 27: 317-321.
51. Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004; 6: 159-166.
52. Mehta NB. The chemistry of bupropion. J Clin Psychiatry 1983; 44 Sec 2: 56-59.
53. Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004; 27: 560-83.
54. Murphy DL, Sunderland T, Cohen RM. Monoamine oxidase-inhibiting antidepressants. A Clinical update. Psychiatr Clin North Am 1984; 7: 546-562.
55. Remick RA, Froese C, Keller FD. Common side effects associated with monoamine oxidase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13: 497-504.
56. Papakostas GI. Major depressive disorder: similar remission rates with bupropion, sertraline, or venlafaxine following treatment switch from citalopram. Evid Based Ment Health 2006; 9: 100.
57. Nieuwstraten CE, Dolovich LR. Buprupion versus selective serotonin-reuptake inhibitors for treatment of depression. Ann Pharmacother 2001; 35: 1608-13.
58. Papakostas GI, Nutt DJ, Tucker VL, Krishen A, Fava M. Resolution of sleepiness and fatigue in the treatment of major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry 2006; 60: 1350-1355.
59. Feighner J, Hendrickson G, Miller L, Stern W. Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder. J Clin Psychopharmacol 1986; 6: 27-32.
60. Thase ME, Clayton AH, Haight BR, Thompson AH, Modell JG, Johnston JA. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. J Clin Psychopharm. 2006; 26: 482-488.
61. Clayton AH, Croft HA, Horrigan JP, et al. Bupropion extended released compared with Escitalopram: Effects on sexual functioning and antidepressant efficacy in two randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 2006; 67: 736-746.
62. Croft H, Settle E, Houser T, Batey SR, Donahue RM, Ascher JA. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999; 21; 643-658.
63. Coleman CC, Cunningham LA, Foster VJ, et al. Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained-release and sertraline treatment. Ann Clin Psychiatry 1999; 11: 205-215.
64. Coleman CC, King BR, Bolden-Watson C, et al. A placebo-controlled comparison on sexual functioning of bupropion SR and fluoxetine. Clin Ther 2001; 23: 1040-1058.
65. Product Prescribing Information. In: Physician's Desk Reference. Montvale, NJ: Thomson PDR; 2005.
66. Kavoussi RJ, Seagraves RT, Hughes AR, Ascher JA, Johnston JA. Doubleblind comparison of bupropion SR and sertraline in depressed outpatients. J Clin Psychiatry 1997; 58: 532-537.
67. Weihs KL, Settle EC, Batey SR, Houser TL, Donahue RM, Ascher JA. Bupropion sustained-release versus paroxetine for the treatment of depression in the elderly. J Clin Psychiatry 2000; 61: 196-202.
68. Weihs KL, Houser TL, Batey SR, et al. Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression. Biol Psychiatry 2002; 51: 753-761.
69. Rush AJ, Carmody TJ, Haight BR, Rockett CB, Zisook S. Does pretreatment insomnia or anxiety predict acute response to bupropion SR? Ann Clin Psychiatry 2005; 17: 1-9.
70. Nofzinger EA, Reynolds CF, Thase ME, et al. REM sleep enhancement by bupropion in depressed men. Am J Psychiatry 1995; 152: 274-276.
71. Nofzinger EA, Fasiczka MA, Berman S, Thase ME. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder, J Clin Psychiatry 2000; 61: 858-862.
72. 18F]-FDG PET. Psychiatry Research: Neuroimaging 2001; 106: 95-111.
73. Evans L, Golshan S, Kelsoe J, et al. Effects of rapid tryptophan depletion on sleep electroencephalogram and mood in subjects with partially remitted depression on bupropion. Neuropsychopharmacology 2002; 27: 1016-1026.
74. Ott GE, Rai U, Nuccio I, Lin KM, Poland RE. Effect of bupropion SR on REM sleep: relationship to antidepressant response. Psychopharmacology 2002; 165: 29-36.
75. Ott GE, Rao U, Lin KM, Girtsik L, Poland RE. Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response. Int J Neuropsychopharmacol 2001; 7: 275-281.
76. Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry. 2005; 58: 510-514.
77. Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg HP. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology 1994; 10: 123-127.